Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02610816 · ClinicalTrials.gov registry record · Phase 2
Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids
A Phase 2 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
NCT02610816 is a Phase 2 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 67 participants.
The verdict
NCT02610816, a Phase 2 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this interventional study is to test and compare the effectiveness of two elimination diets-the 1-food elimination diet (1FED, milk only) and the 4-food elimination diet (4FED, milk, egg, wheat, and soy) for eosinophilic esophagitis (EoE). The study will also test the effectiveness of swallowed glucocorticoid therapy in some of the study participants for whom diet therapy was not effective.
Interventions
- OTHER 1 Food Elimination Diet
- OTHER 4 Food Elimination Diet
- OTHER 4 Food Elimination Diet (post 1FED failure)
- DRUG Fluticasone Propionate, 800 mcg twice daily (post 4FED failure)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2016-03-21 |
| Est. Completion | 2018-05-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02610816
The ClinicalTrials.gov registry entry for NCT02610816 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which 1 Food Elimination Diet is the first listed.
NCT02610816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02610816 about?
NCT02610816 is a clinical study titled "Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids". The purpose of this interventional study is to test and compare the effectiveness of two elimination diets-the 1-food elimination diet (1FED, milk only) and the 4-food elimination diet (4FED, milk, egg, wheat, and soy) for eosinophilic esophagitis (EoE). The study will also test the effectiveness of...
What is the current status of trial NCT02610816?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2016-03-21. Estimated completion is 2018-05-16.
What interventions are being tested in trial NCT02610816?
The interventions under investigation include: 1 Food Elimination Diet (OTHER), 4 Food Elimination Diet (OTHER), 4 Food Elimination Diet (post 1FED failure) (OTHER), Fluticasone Propionate, 800 mcg twice daily (post 4FED failure) (DRUG).
Who is sponsoring clinical trial NCT02610816?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.